Aspirin in Primary Prevention: Lessons From ARRIVE Aspirin in Primary Prevention: Lessons From ARRIVE

The ARRIVE trial compared low-dose aspirin with placebo in middle-aged men and women at moderate CV risk. Investigator J. Michael Gaziano gives John Mandrola the details.theheart.org on Medscape
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Cardiology Commentary Source Type: news